NewAmsterdam Pharma Company
NAMS
#4448
Rank
C$2.58 B
Marketcap
$27.95
Share price
-15.50%
Change (1 day)
114.37%
Change (1 year)

Earnings for NewAmsterdam Pharma Company (NAMS)

Earnings in 2024 (TTM): -C$0.25 Billion

According to NewAmsterdam Pharma Company's latest financial reports the company's current earnings are C$14.02 Million. In 2023 the company made an earning of -C$0.25 Billion a decrease over its 2022 earnings that were of -C$33.92 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for NewAmsterdam Pharma Company from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.25 Billion0.45%
2023 -C$0.25 Billion628.66%
2022-C$33.92 Million-48.69%
2021-C$66.1 Million444.1%
2020-C$12.15 Million